Synonyms Recurrent Transformed B-Cell Non-Hodgkin Lymphoma, Recurrent Transformed Indolent B-Cell Non-Hodgkin Lymphoma |
Introduction The reemergence of B-cell non-Hodgkin lymphoma transformed after a period of remission. |
Target |
Mechanism PI3Kα inhibitors [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date14 Sep 2017 |
Target |
Mechanism CD79B inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Start Date20 Jul 2024 |
Sponsor / Collaborator |
Start Date29 Jan 2024 |
Sponsor / Collaborator |
Start Date02 Jan 2024 |
Sponsor / Collaborator |